• Latest
• Popular

Tag "research"

• 
  The synthetic lethality-based drugs and targets market is estimated to be worth USD 8 billion in 2030, predicts Roots Analysis
  

  Posted by Jordan Smith on January 4 at 10:03 . 0 likes
• 
  The synthetic lethality-based drugs and targets market is projected to grow at an annualized rate of ~18%, till 2030
  

  Posted by Jordan Smith on January 4 at 10:04 . 0 likes
• 
  About 75 drug candidates based on synlet gene pairs are being evaluated for the treatment of various types of cancers; presently, there are over 20 screening platforms enabling therapy development efforts
  

  Posted by Jordan Smith on January 4 at 10:06 . 0 likes
• 
  Synthetic Lethality-based Drugs and Targets Market, 2019-2030: Focus on DNA Repair
  

  Posted by Jordan Smith on January 4 at 10:06 . 0 likes
• 
  The targeted protein degradation market is projected to grow at an annualized rate of more than 30% till 2030
  

  Posted by Jordan Smith on January 4 at 10:08 . 0 likes
• 
  More than 85 small molecule protein degraders are currently being evaluated for the treatment of various disease indications; in addition, there are over 25 technology platforms available for use in therapy development efforts
  

  Posted by Jordan Smith on January 4 at 10:09 . 0 likes
• 
  The “Targeted Protein Degradation Market, 2020-2030” report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapeutics and affiliated technologies, over the next decade.
  

  Posted by Jordan Smith on January 4 at 10:09 . 0 likes
• 
  The synthetic lethality-based drugs and targets market is estimated to be worth USD 8 billion in 2030, predicts Roots Analysis
  

  Posted by Jordan Smith on January 5 at 8:58 . 0 likes
• 
  The synthetic lethality-based drugs and targets market is projected to grow at an annualized rate of ~18%, till 2030
  

  Posted by Jordan Smith on January 5 at 9:01 . 0 likes
• 
  About 75 drug candidates based on synlet gene pairs are being evaluated for the treatment of various types of cancers; presently, there are over 20 screening platforms enabling therapy development efforts
  

  Posted by Jordan Smith on January 5 at 9:01 . 0 likes
• 
  Synthetic Lethality-based Drugs and Targets Market, 2019-2030: Focus on DNA Repair
  

  Posted by Jordan Smith on January 5 at 9:02 . 0 likes
• 
  The targeted protein degradation market is projected to grow at an annualized rate of more than 30% till 2030
  

  Posted by Jordan Smith on January 5 at 9:04 . 0 likes
• 
  More than 85 small molecule protein degraders are currently being evaluated for the treatment of various disease indications; in addition, there are over 25 technology platforms available for use in therapy development efforts
  

  Posted by Jordan Smith on January 5 at 9:04 . 0 likes
• 
  The “Targeted Protein Degradation Market, 2020-2030” report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapeutics and affiliated technologies, over the next decade.
  

  Posted by Jordan Smith on January 5 at 9:05 . 0 likes
• 
  The STING pathway targeting technologies market, featuring a healthy pipeline of therapeutics, is anticipated to be worth over USD 2.8 billion by 2030, predicts Roots Analysis
  

  Posted by Jordan Smith on January 6 at 9:44 . 0 likes
• 
  The STING pathway targeting technologies market is projected to grow at an annualized rate of ~25%, till 2030
  

  Posted by Jordan Smith on January 6 at 9:45 . 0 likes
• 
  Many small / macro molecule-based STING pathway modulators are currently being evaluated as monotherapies as well as in combination with other drugs, claims Roots Analysis
  

  Posted by Jordan Smith on January 6 at 9:45 . 0 likes
• 
  The “STING Pathway Targeting Therapeutics and Technologies, 2020-2030” report features an extensive study of the current market landscape and future potential of these therapeutics and affiliated technologies, over the next decade.
  

  Posted by Jordan Smith on January 6 at 9:46 . 0 likes
• 
  The subcutaneous biologic drugs and affiliated technologies market is projected to be worth over USD 180 billion by 2030, predicts Roots Analysis
  

  Posted by Jordan Smith on January 6 at 9:47 . 0 likes
• 
  The subcutaneous biologic drugs and affiliated technologies market is projected to be worth over USD 180 billion by 2030, predicts Roots Analysis
  

  Posted by Jordan Smith on January 6 at 9:47 . 0 likes
• 
  The subcutaneous biologic drugs and affiliated technologies market is projected to be worth over USD 180 billion by 2030
  

  Posted by Jordan Smith on January 6 at 9:48 . 0 likes
• 
  More than 100 subcutaneous biologics have been approved and over 350 such drug candidates are being evaluated in the clinical stages of development, for the treatment of a wide variety of disease indications, claims Roots Analysis
  

  Posted by Jordan Smith on January 6 at 9:49 . 0 likes
• 
  The contract fill / finish services market for biologics is anticipated to be worth USD 4.2 billion by 2030, predicts Roots Analysis
  

  Posted by Jordan Smith on January 7 at 10:30 . 0 likes
• 
  The contract fill / finish services market for biologics market is projected to grow at an annualized rate of ~10%, till 2030
  

  Posted by Jordan Smith on January 7 at 10:32 . 0 likes